Research Peptide Comparison
Tirzepatide 60mg and Tirzepatide Pen 60mg are both GLP-1 Peptides research peptides available from Neovia Peptides. This comparison highlights the key differences in specifications, pricing, and availability to help inform your research decisions.
Tirzepatide is a synthetic peptide that activates both the GLP-1 and GIP receptors, producing simultaneous engagement of the two principal incretin pathways. This combined receptor profile underpins its role in research into glucose homeostasis, weight regulation and pancreatic hormone signalling, and has established it as one of the most-studied dual incretin agonists in modern metabolic research.
Compared to Tirzepatide Pen 60mg, Tirzepatide 60mg is priced at £164.99 with 99.5%+ verified purity. Its CAS registry number is 2023788-19-2. It has a molecular weight of 4813.52 g/mol.
Tirzepatide 60mg is available in 15mg, 30mg, 60mg and ships with a full Certificate of Analysis from Janoshik Analytical. At £35.01 less than Tirzepatide Pen 60mg, it is the more affordable option in this comparison.
Tirzepatide is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. By activating both incretin pathways simultaneously, it has become one of the most-studied molecules in modern metabolic and obesity research.
Compared to Tirzepatide 60mg, Tirzepatide Pen 60mg is priced at £200.00 with 99.5%+ verified purity. Its CAS registry number is 2023788-19-2. It has a molecular weight of 4813.52 g/mol.
Tirzepatide Pen 60mg is available in 30mg, 60mg and ships with a full Certificate of Analysis from Janoshik Analytical. It is priced £35.01 higher than Tirzepatide 60mg.
All products sold by Neovia Peptides are strictly for in-vitro research and laboratory use only. Not intended for human or veterinary use, food additives, drugs, or cosmetics. By purchasing from this website, you agree that you understand and accept these terms.
